Save your place

Sign in to WhoBought

Please try again later.

Jeremy Grantham's Elevance Health Inc. (ELV) position

Yes: as of Q1 2026, Jeremy Grantham holds 1.9M shares of ELV worth $567M (1.4% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$567M
Shares held
1.9M
% of portfolio
1.4%
Est. average buy price (i)
$404.12
est. since Q1 2021
Quarter-end price
$292.75

Estimated trade prices

Average price in quarters with purchases
$430.84
Average prices in quarters with sales
  • Q1 2026: $328.64 (593K shares sold)
  • Q2 2025: $402.22 (119K shares sold)
  • Q4 2022: $507.74 (5K shares sold)
  • Q3 2022: $478.49 (15K shares sold)
  • Q2 2022: $494.71 (203K shares sold)
  • Q1 2022: $457.10 (169K shares sold)
  • Q4 2021: $420.70 (40K shares sold)

ELV price vs Grantham's position

1Y 3Y 5Y MAX
Dates
$200$400$60020222023202420252026Added 97K shares (9.2%) · Q3 2021. Average closing price $380.04 · Price range $357.51–$398.1397KsharespurchasedSold 40K shares (3.5%) · Q4 2021. Average closing price $420.70 · Price range $370.08–$467.6740KsharessoldSold 169K shares (15.4%) · Q1 2022. Average closing price $457.10 · Price range $428.44–$502.48169KsharessoldSold 203K shares (21.8%) · Q2 2022. Average closing price $494.71 · Price range $444.32–$529.84203KsharessoldSold 15K shares (2.1%) · Q3 2022. Average closing price $478.49 · Price range $445.98–$507.0015KsharessoldSold 5K shares (0.7%) · Q4 2022. Average closing price $507.74 · Price range $465.23–$546.775KsharessoldAdded 9K shares (1.3%) · Q1 2023. Average closing price $475.89 · Price range $446.30–$502.209KsharespurchasedAdded 113K shares (15.7%) · Q2 2023. Average closing price $461.32 · Price range $436.33–$496.20113KsharespurchasedAdded 59K shares (7.1%) · Q3 2023. Average closing price $453.58 · Price range $414.13–$475.9359KsharespurchasedAdded 29K shares (3.2%) · Q4 2023. Average closing price $462.41 · Price range $433.51–$488.0629KsharespurchasedAdded 329K shares (35.8%) · Q1 2024. Average closing price $497.33 · Price range $464.61–$519.96329KsharespurchasedAdded 103K shares (8.2%) · Q2 2024. Average closing price $528.58 · Price range $497.49–$547.80103KsharespurchasedAdded 335K shares (24.8%) · Q3 2024. Average closing price $534.22 · Price range $500.12–$562.29335KsharespurchasedAdded 316K shares (18.8%) · Q4 2024. Average closing price $418.46 · Price range $365.96–$511.26316KsharespurchasedAdded 158K shares (7.9%) · Q1 2025. Average closing price $401.43 · Price range $365.83–$436.25158KsharespurchasedSold 119K shares (5.5%) · Q2 2025. Average closing price $402.22 · Price range $372.27–$452.69119KsharessoldAdded 483K shares (23.7%) · Q3 2025. Average closing price $311.02 · Price range $274.66–$395.76483KsharespurchasedAdded 8K shares (0.3%) · Q4 2025. Average closing price $338.05 · Price range $303.78–$362.348KsharespurchasedSold 593K shares (23.4%) · Q1 2026. Average closing price $328.64 · Price range $280.74–$381.93593Ksharessold← Earlier —1 purchase
Average closing price · filing quarter
$328.64
Price range · filing quarter
$280.74 – $381.93
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −593K −$195M −23.4% 1.9M May 14, 2026
Q4 2025 Added +8K +$2.6M +0.3% 2.5M Feb 17, 2026
Q3 2025 Added +483K +$150M +23.7% 2.5M Nov 13, 2025
Q2 2025 Reduced −119K −$48M −5.5% 2.0M Aug 13, 2025
Q1 2025 Added +158K +$64M +7.9% 2.2M May 14, 2025
Q4 2024 Added +316K +$132M +18.8% 2.0M Feb 13, 2025
Q3 2024 Added +335K +$179M +24.8% 1.7M Nov 13, 2024
Q2 2024 Added +103K +$54M +8.2% 1.3M Aug 13, 2024
Q1 2024 Added +329K +$163M +35.8% 1.2M May 14, 2024
Q4 2023 Added +29K +$13M +3.2% 919K Feb 13, 2024
Q3 2023 Added +59K +$27M +7.1% 890K Nov 13, 2023
Q2 2023 Added +113K +$52M +15.7% 831K Aug 14, 2023
Q1 2023 Added +9K +$4.4M +1.3% 718K May 12, 2023
Q4 2022 Reduced −5K −$2.7M −0.7% 709K Feb 13, 2023
Q3 2022 Reduced −15K −$7.4M −2.1% 714K Nov 10, 2022
Q2 2022 Reduced −203K −$100M −21.8% 730K Aug 12, 2022
Q1 2022 Reduced −169K −$77M −15.4% 933K May 13, 2022
Q4 2021 Reduced −40K −$17M −3.5% 1.1M Feb 11, 2022
Q3 2021 Added +97K +$37M +9.2% 1.1M Nov 12, 2021
Q2 2021 Added +10K +$3.8M +1.0% 1.0M Aug 12, 2021
Q1 2021 First covered – – – 1.0M May 13, 2021
Data through Q1 2026 · filed May 14, 2026
21 grouped rows from 21 quarters

Who else owns ELV

Wellington Management Group LLP
owns 3.8% of shares outstanding
Est. $2.4B · Shares: 8.2M

Sanders Capital, LLC
owns 2.7% of shares outstanding
Est. $1.7B · Shares: 5.9M

Artisan Partners Limited Partnership
owns 2.4% of shares outstanding
Est. $1.5B · Shares: 5.1M

Invesco Ltd.

 View investor →
owns 2.2% of shares outstanding
Est. $1.4B · Shares: 4.8M

See all owners of ELV →

More Grantham positions

Microsoft Corporation(MSFT)
$2.3B
5.8% of portfolio

Alphabet Inc.(GOOGL)
$1.9B
5.1% of portfolio

Johnson & Johnson(JNJ)
$1.8B
4.6% of portfolio

Apple Inc.(AAPL)
$1.8B
4.5% of portfolio

Meta Platforms, Inc.(META)
$1.7B
4.5% of portfolio

Lam Research Corporation(LRCX)
$1.4B
3.8% of portfolio

Common questions

Does Jeremy Grantham own ELV?

Yes. As of Q1 2026, Jeremy Grantham disclosed 1.9M shares of ELV, worth $567M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jeremy Grantham buy ELV?

Jeremy Grantham held ELV since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jeremy Grantham sell ELV?

The quarter-by-quarter table above shows each sale and reduction Jeremy Grantham disclosed in ELV. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ELV does Jeremy Grantham own?

Jeremy Grantham disclosed 1.9M shares of ELV as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jeremy Grantham pay for ELV?

Jeremy Grantham began building the ELV position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.